Real-time enrollment status for this advanced solid tumor clinical trial
Current Status
Recruiting
Checked: September 22, 2026 at 2:15 AM UTC
| NCT Number | NCT07629960 |
| Recruiting Status | Recruiting |
| Condition | Advanced Solid Tumor |
| Phase | PHASE1 |
| Target Enrollment | 265 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Blueprint Medicines Corporation |
| Last Updated on CT.gov | September 21, 2026 (Yesterday) |
As of September 22, 2026: Clinical trial NCT07629960 is currently recruiting participants. This phase1 study for advanced solid tumor is actively seeking new participants at 10 locations across the United States. The study is sponsored by Blueprint Medicines Corporation. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07629960 is actively recruiting participants as of September 22, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07629960 was last updated Yesterday (September 21, 2026). HelloStudys verifies this status automatically.